These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 12445661)

  • 1. Human papillomavirus immortalization and transformation functions.
    Münger K; Howley PM
    Virus Res; 2002 Nov; 89(2):213-28. PubMed ID: 12445661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular targets of the oncoproteins encoded by the cancer associated human papillomaviruses.
    Howley PM; Münger K; Romanczuk H; Scheffner M; Huibregtse JM
    Princess Takamatsu Symp; 1991; 22():239-48. PubMed ID: 1668886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Warts, cancer and ubiquitylation: lessons from the papillomaviruses.
    Howley PM
    Trans Am Clin Climatol Assoc; 2006; 117():113-26; discussion 126-7. PubMed ID: 18528468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Papillomavirus E6 and E7 proteins and their cellular targets.
    Wise-Draper TM; Wells SI
    Front Biosci; 2008 Jan; 13():1003-17. PubMed ID: 17981607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus proteins as prospective therapeutic targets.
    Pang CL; Thierry F
    Microb Pathog; 2013 May; 58():55-65. PubMed ID: 23164805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of HPV E6 and E7 oncoproteins with tumour suppressor gene products.
    Münger K; Scheffner M; Huibregtse JM; Howley PM
    Cancer Surv; 1992; 12():197-217. PubMed ID: 1322242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms underlying human papillomavirus E6 and E7 oncoprotein-induced cell transformation.
    Mittal S; Banks L
    Mutat Res Rev Mutat Res; 2017; 772():23-35. PubMed ID: 28528687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein intrinsic disorder and human papillomaviruses: increased amount of disorder in E6 and E7 oncoproteins from high risk HPVs.
    Uversky VN; Roman A; Oldfield CJ; Dunker AK
    J Proteome Res; 2006 Aug; 5(8):1829-42. PubMed ID: 16889404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Functions of the Human Papillomavirus E6 Oncoproteins.
    Wallace NA; Galloway DA
    Annu Rev Virol; 2015 Nov; 2(1):403-23. PubMed ID: 26958922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses.
    Heck DV; Yee CL; Howley PM; Münger K
    Proc Natl Acad Sci U S A; 1992 May; 89(10):4442-6. PubMed ID: 1316608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus E6 and E7 oncoproteins alter cell cycle progression but not radiosensitivity of carcinoma cells treated with low-dose-rate radiation.
    DeWeese TL; Walsh JC; Dillehay LE; Kessis TD; Hedrick L; Cho KR; Nelson WG
    Int J Radiat Oncol Biol Phys; 1997 Jan; 37(1):145-54. PubMed ID: 9054890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus type 16 E6 and E7 proteins inhibit differentiation-dependent expression of transforming growth factor-beta2 in cervical keratinocytes.
    Nees M; Geoghegan JM; Munson P; Prabhu V; Liu Y; Androphy E; Woodworth CD
    Cancer Res; 2000 Aug; 60(15):4289-98. PubMed ID: 10945644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms of transformation by the human papillomaviruses.
    Howley PM; Münger K; Werness BA; Phelps WC; Schlegel R
    Princess Takamatsu Symp; 1989; 20():199-206. PubMed ID: 2562182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of human papillomavirus type 16 E7 activity through direct protein interaction with the E2 transcriptional activator.
    Gammoh N; Grm HS; Massimi P; Banks L
    J Virol; 2006 Feb; 80(4):1787-97. PubMed ID: 16439535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomaviruses: targeting differentiating epithelial cells for malignant transformation.
    Fehrmann F; Laimins LA
    Oncogene; 2003 Aug; 22(33):5201-7. PubMed ID: 12910257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the Wnt/β-Catenin Signaling Pathway by Human Papillomavirus E6 and E7 Oncoproteins.
    Bello JO; Nieva LO; Paredes AC; Gonzalez AM; Zavaleta LR; Lizano M
    Viruses; 2015 Aug; 7(8):4734-55. PubMed ID: 26295406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological activities and molecular targets of the human papillomavirus E7 oncoprotein.
    Münger K; Basile JR; Duensing S; Eichten A; Gonzalez SL; Grace M; Zacny VL
    Oncogene; 2001 Nov; 20(54):7888-98. PubMed ID: 11753671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repression of Human Papillomavirus Oncogene Expression under Hypoxia Is Mediated by PI3K/mTORC2/AKT Signaling.
    Bossler F; Kuhn BJ; Günther T; Kraemer SJ; Khalkar P; Adrian S; Lohrey C; Holzer A; Shimobayashi M; Dürst M; Mayer A; Rösl F; Grundhoff A; Krijgsveld J; Hoppe-Seyler K; Hoppe-Seyler F
    mBio; 2019 Feb; 10(1):. PubMed ID: 30755508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Papillomavirus E7 oncoproteins share functions with polyomavirus small T antigens.
    White EA; Kramer RE; Hwang JH; Pores Fernando AT; Naetar N; Hahn WC; Roberts TM; Schaffhausen BS; Livingston DM; Howley PM
    J Virol; 2015 Mar; 89(5):2857-65. PubMed ID: 25540383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papilloma virus (HPV) and host cellular interactions.
    Mammas IN; Sourvinos G; Giannoudis A; Spandidos DA
    Pathol Oncol Res; 2008 Dec; 14(4):345-54. PubMed ID: 18493868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.